These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 19432621)

  • 1. Accidental pregnancy exposure to verteporfin: obstetrical and neonatal outcomes: a case report.
    Rodrigues M; Meira D; Batista S; Carrilho MM
    Aust N Z J Obstet Gynaecol; 2009 Apr; 49(2):236-7. PubMed ID: 19432621
    [No Abstract]   [Full Text] [Related]  

  • 2. Acute respiratory distress due to verteporfin infusion for photodynamic therapy.
    Fossarello M; Peiretti E
    Arch Ophthalmol; 2006 Oct; 124(10):1509-10. PubMed ID: 17030732
    [No Abstract]   [Full Text] [Related]  

  • 3. First case of post-conception Verteporfin exposure: pregnancy and neonatal outcome.
    De Santis M; Carducci B; De Santis L; Lucchese A; Straface G
    Acta Ophthalmol Scand; 2004 Oct; 82(5):623-4. PubMed ID: 15453867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Choroidal infarction following photodynamic therapy with verteporfin.
    Klais CM; Ober MD; Freund KB; Ginsburg LH; Luckie A; Mauget-Faÿsse M; Coscas G; Gross NE; Yannuzzi LA
    Arch Ophthalmol; 2005 Aug; 123(8):1149-53. PubMed ID: 16087856
    [No Abstract]   [Full Text] [Related]  

  • 5. A potentially life-threatening adverse reaction to verteporfin.
    Noffke AS; Jampol LM; Weinberg DV; Muñana A
    Arch Ophthalmol; 2001 Jan; 119(1):143. PubMed ID: 11146745
    [No Abstract]   [Full Text] [Related]  

  • 6. Bilateral punctal-canalicular stenosis following photodynamic therapy for choroidal neovascularization.
    Yim JF; Crofts KP
    Cutan Ocul Toxicol; 2011 Mar; 30(1):78-9. PubMed ID: 20950246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased and persisted subretinal haemorrhage after photodynamic therapy for choroidal neovascularization secondary to angioid streaks.
    Shyong MP; Chen SJ; Lee FL; Tsao YP; Hsu WM
    Eye (Lond); 2006 Dec; 20(12):1420-2. PubMed ID: 16645630
    [No Abstract]   [Full Text] [Related]  

  • 8. Choroidal ischemia after photodynamic therapy with verteporfin for choroidal neovascularization.
    Isola V; Pece A; Parodi MB
    Am J Ophthalmol; 2006 Oct; 142(4):680-3. PubMed ID: 17011867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retinopathy associated with photodynamic therapy for treatment of idiopathic choroidal neovascularization.
    Sii F; Lee LR
    Clin Exp Ophthalmol; 2006 Mar; 34(2):184-6. PubMed ID: 16626441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonarteritic anterior ischemic optic neuropathy after photodynamic therapy for choroidal neovascularization.
    Karacorlu M; Karacorlu S; Ozdemir H
    Jpn J Ophthalmol; 2004; 48(4):424-6. PubMed ID: 15295679
    [No Abstract]   [Full Text] [Related]  

  • 11. Verteporfin therapy combined with intravitreal triamcinolone in all types of choroidal neovascularization due to age-related macular degeneration.
    Augustin AJ; Schmidt-Erfurth U
    Ophthalmology; 2006 Jan; 113(1):14-22. PubMed ID: 16360209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Verteporfin and photosensitivity in diabetic].
    Asensio Sánchez VM; Corral Azor A; García Pascual A
    Arch Soc Esp Oftalmol; 2003 May; 78(5):277-9. PubMed ID: 12789632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Verteporfin and intravitreal triamcinolone acetonide combination therapy for occult choroidal neovascularization in age-related macular degeneration.
    Augustin AJ; Schmidt-Erfurth U
    Am J Ophthalmol; 2006 Apr; 141(4):638-45. PubMed ID: 16564797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Photodynamic therapy with verteporfin for subfoveal choroidal neovascularization secondary to pathologic myopia: long-term study.
    Pece A; Isola V; Vadalà M; Matranga D
    Retina; 2006 Sep; 26(7):746-51. PubMed ID: 16963846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apparent disappearance of choroidal neovascularization after initial photodynamic therapy with verteporfin.
    Sawa M; Ohji M; Gomi F; Kusaka S; Tano Y; Bressler NM
    Arch Ophthalmol; 2002 Nov; 120(11):1588-90. PubMed ID: 12427082
    [No Abstract]   [Full Text] [Related]  

  • 16. Verteporfin therapy and intravitreal bevacizumab combined and alone in choroidal neovascularization due to age-related macular degeneration.
    Lazic R; Gabric N
    Ophthalmology; 2007 Jun; 114(6):1179-85. PubMed ID: 17544776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abnormal response of the retinal pigment epithelium to photodynamic therapy in a child.
    Diaz M; Cervera E; Hernandez M; Salom D
    Retina; 2006 Sep; 26(7):834-6. PubMed ID: 16963864
    [No Abstract]   [Full Text] [Related]  

  • 18. Verteporfin therapy for choroidal neovascularization: from concept to proof of efficacy.
    Sickenberg M
    Semin Ophthalmol; 2001 Dec; 16(4):177-80. PubMed ID: 15513439
    [No Abstract]   [Full Text] [Related]  

  • 19. Treatment of juxtafoveal choroidal neovascularization with photodynamic therapy using verteporfin in eyes with age-related macular degeneration.
    Hariprasad SM; Shah GK
    Ophthalmic Surg Lasers Imaging; 2005; 36(3):258-60. PubMed ID: 15957487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Large submacular hemorrhages after verteporfin therapy.
    Do DV; Bressler NM; Bressler SB
    Am J Ophthalmol; 2004 Mar; 137(3):558-60. PubMed ID: 15013883
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.